We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
+14.02%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$1.4B
AUM Growth
+$158M
(+13%)
Cap. Flow
-$1.2M
Cap. Flow
% of AUM
-0.09%
Top 10 Holdings %
Top 10 Hldgs %
25.79%
Holding
334
New
27
Increased
115
Reduced
154
Closed
6
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total World Stock ETF
VT
|
+$2.39M |
| 2 |
Vanguard Emerging Markets Government Bond ETF
VWOB
|
+$2.14M |
| 3 |
Vanguard Energy ETF
VDE
|
+$1.56M |
| 4 |
Home Depot
HD
|
+$1.26M |
| 5 |
Microsoft
MSFT
|
+$1.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ionis Pharmaceuticals
IONS
|
+$4.98M |
| 2 |
iShares Micro-Cap ETF
IWC
|
+$4.31M |
| 3 |
Vanguard Morningstar Small-Cap ETF
VB
|
+$1.53M |
| 4 |
Reliance Steel & Aluminium
RS
|
+$1.09M |
| 5 |
MZTI
The Marzetti Company
MZTI
|
+$997K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.42% |
| 2 | Technology | 17.34% |
| 3 | Healthcare | 12.27% |
| 4 | Financials | 10.7% |
| 5 | Consumer Staples | 9.66% |
Similar funds
AC
CCM
MIAN
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q4 2020 Portfolio in Review
As of Q4 2020, Dowling & Yahnke held 334 positions worth $1.4B, up 13% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dowling & Yahnke's Q4 2020 filing shows 27 new, 115 increased, 154 reduced and 6 closed positions. Its largest new stake was Vanguard Total World Stock ETF: 27,592 shares worth $2.55M. The largest sale was Ionis Pharmaceuticals, an estimated $4.98M.
By sector, the portfolio is most concentrated in Miscellaneous at 24% of assets, up from 24% a quarter earlier, followed by Technology and Healthcare.
- Dowling & Yahnke's largest Q4 2020 buy was Vanguard Total World Stock ETF: 27,592 shares worth $2.55M.
- Dowling & Yahnke added most to Vanguard Emerging Markets Government Bond ETF in Q4 2020, an estimated $2.14M increase.
- Dowling & Yahnke's biggest Q4 2020 reduction was Ionis Pharmaceuticals, cutting an estimated $4.98M.
- Dowling & Yahnke fully exited Schrodinger in Q4 2020, selling an estimated $467K.
- Dowling & Yahnke's ten largest holdings make up 26% of its $1.4B portfolio in Q4 2020.
- Dowling & Yahnke opened 27 new positions and closed 6 in Q4 2020.
- Dowling & Yahnke's portfolio value rose 13% quarter-over-quarter to $1.4B.
Based on Dowling & Yahnke's 13F filing for Q4 2020, filed 28 Jan 2021.